Cargando…

Subcutaneous Emphysema, Pneumomediastinum, and Pneumothorax in Critically Ill Patients With Coronavirus Disease 2019: A Retrospective Cohort Study

IMPORTANCE: Management of severe coronavirus disease 2019 relies on advanced respiratory support modalities including invasive mechanical ventilation, continuous positive airway pressure, and noninvasive ventilation, all of which are associated with the development of subcutaneous emphysema, pneumom...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Eben, Gould, Allon, Pillay, Timesh D., Khorasanee, Reza, Sykes, Richard, Bazo-Alvarez, Juan Carlos, Cox, Charlie, Shurovi, Badrun, Isted, Alexander, Simpson, Thomas, Jennings, Mick, Breeze, Richard, Khaliq, Waqas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515614/
https://www.ncbi.nlm.nih.gov/pubmed/33063043
http://dx.doi.org/10.1097/CCE.0000000000000210
_version_ 1783586842151485440
author Jones, Eben
Gould, Allon
Pillay, Timesh D.
Khorasanee, Reza
Sykes, Richard
Bazo-Alvarez, Juan Carlos
Cox, Charlie
Shurovi, Badrun
Isted, Alexander
Simpson, Thomas
Jennings, Mick
Breeze, Richard
Khaliq, Waqas
author_facet Jones, Eben
Gould, Allon
Pillay, Timesh D.
Khorasanee, Reza
Sykes, Richard
Bazo-Alvarez, Juan Carlos
Cox, Charlie
Shurovi, Badrun
Isted, Alexander
Simpson, Thomas
Jennings, Mick
Breeze, Richard
Khaliq, Waqas
author_sort Jones, Eben
collection PubMed
description IMPORTANCE: Management of severe coronavirus disease 2019 relies on advanced respiratory support modalities including invasive mechanical ventilation, continuous positive airway pressure, and noninvasive ventilation, all of which are associated with the development of subcutaneous emphysema, pneumomediastinum, and pneumothorax (herein collectively termed barotrauma). OBJECTIVES: To assess the occurrence rate of barotrauma in severe coronavirus disease 2019 and to explore possible associated factors. DESIGN, SETTING, AND PARTICIPANTS: A retrospective, single-center cohort study with nested case series, conducted at University Hospital Lewisham: a 450-bed general hospital in London, United Kingdom. All patients with confirmed coronavirus disease 2019 admitted to the critical care department from March 12, to April 12, 2020, were included. MAIN OUTCOMES AND MEASURES: Patients were retrospectively screened for radiological evidence of barotrauma. Admission characteristics, modalities of respiratory support, and outcomes were compared between barotrauma and nonbarotrauma groups. Respiratory parameters in the period preceding barotrauma identification were recorded. RESULTS: Of 83 admissions with coronavirus disease 2019, eight suffered barotrauma (occurrence rate 9.6%; 95% CI 4.3%–18.1%). Barotrauma cases had longer illness duration prior to critical care admission (10 vs 7 d; interquartile range, 8–14 and 6–10, respectively; p = 0.073) and were more often treated with continuous positive airway pressure or noninvasive ventilation as the initial modality of advanced respiratory support (87.5% vs 36.0%; p = 0.007). Patients managed with continuous positive airway pressure or noninvasive ventilation prior to the development of barotrauma had median minute ventilation of 16.2–19.9 and 21.3–22.7 L/min, respectively. Compared with the nonbarotrauma group, a higher proportion of patients with barotrauma had died (62.5% vs 43.2%), and a lower proportion of patients had been discharged (25.0% vs 53.3%) at 3-month follow-up. CONCLUSIONS AND RELEVANCE: Barotrauma appears to be a common complication of severe coronavirus disease 2019. Determining whether high minute ventilation while using continuous positive airway pressure or noninvasive ventilation predisposes patients to barotrauma requires further investigation.
format Online
Article
Text
id pubmed-7515614
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-75156142020-10-14 Subcutaneous Emphysema, Pneumomediastinum, and Pneumothorax in Critically Ill Patients With Coronavirus Disease 2019: A Retrospective Cohort Study Jones, Eben Gould, Allon Pillay, Timesh D. Khorasanee, Reza Sykes, Richard Bazo-Alvarez, Juan Carlos Cox, Charlie Shurovi, Badrun Isted, Alexander Simpson, Thomas Jennings, Mick Breeze, Richard Khaliq, Waqas Crit Care Explor Observational Study IMPORTANCE: Management of severe coronavirus disease 2019 relies on advanced respiratory support modalities including invasive mechanical ventilation, continuous positive airway pressure, and noninvasive ventilation, all of which are associated with the development of subcutaneous emphysema, pneumomediastinum, and pneumothorax (herein collectively termed barotrauma). OBJECTIVES: To assess the occurrence rate of barotrauma in severe coronavirus disease 2019 and to explore possible associated factors. DESIGN, SETTING, AND PARTICIPANTS: A retrospective, single-center cohort study with nested case series, conducted at University Hospital Lewisham: a 450-bed general hospital in London, United Kingdom. All patients with confirmed coronavirus disease 2019 admitted to the critical care department from March 12, to April 12, 2020, were included. MAIN OUTCOMES AND MEASURES: Patients were retrospectively screened for radiological evidence of barotrauma. Admission characteristics, modalities of respiratory support, and outcomes were compared between barotrauma and nonbarotrauma groups. Respiratory parameters in the period preceding barotrauma identification were recorded. RESULTS: Of 83 admissions with coronavirus disease 2019, eight suffered barotrauma (occurrence rate 9.6%; 95% CI 4.3%–18.1%). Barotrauma cases had longer illness duration prior to critical care admission (10 vs 7 d; interquartile range, 8–14 and 6–10, respectively; p = 0.073) and were more often treated with continuous positive airway pressure or noninvasive ventilation as the initial modality of advanced respiratory support (87.5% vs 36.0%; p = 0.007). Patients managed with continuous positive airway pressure or noninvasive ventilation prior to the development of barotrauma had median minute ventilation of 16.2–19.9 and 21.3–22.7 L/min, respectively. Compared with the nonbarotrauma group, a higher proportion of patients with barotrauma had died (62.5% vs 43.2%), and a lower proportion of patients had been discharged (25.0% vs 53.3%) at 3-month follow-up. CONCLUSIONS AND RELEVANCE: Barotrauma appears to be a common complication of severe coronavirus disease 2019. Determining whether high minute ventilation while using continuous positive airway pressure or noninvasive ventilation predisposes patients to barotrauma requires further investigation. Lippincott Williams & Wilkins 2020-09-17 /pmc/articles/PMC7515614/ /pubmed/33063043 http://dx.doi.org/10.1097/CCE.0000000000000210 Text en Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Observational Study
Jones, Eben
Gould, Allon
Pillay, Timesh D.
Khorasanee, Reza
Sykes, Richard
Bazo-Alvarez, Juan Carlos
Cox, Charlie
Shurovi, Badrun
Isted, Alexander
Simpson, Thomas
Jennings, Mick
Breeze, Richard
Khaliq, Waqas
Subcutaneous Emphysema, Pneumomediastinum, and Pneumothorax in Critically Ill Patients With Coronavirus Disease 2019: A Retrospective Cohort Study
title Subcutaneous Emphysema, Pneumomediastinum, and Pneumothorax in Critically Ill Patients With Coronavirus Disease 2019: A Retrospective Cohort Study
title_full Subcutaneous Emphysema, Pneumomediastinum, and Pneumothorax in Critically Ill Patients With Coronavirus Disease 2019: A Retrospective Cohort Study
title_fullStr Subcutaneous Emphysema, Pneumomediastinum, and Pneumothorax in Critically Ill Patients With Coronavirus Disease 2019: A Retrospective Cohort Study
title_full_unstemmed Subcutaneous Emphysema, Pneumomediastinum, and Pneumothorax in Critically Ill Patients With Coronavirus Disease 2019: A Retrospective Cohort Study
title_short Subcutaneous Emphysema, Pneumomediastinum, and Pneumothorax in Critically Ill Patients With Coronavirus Disease 2019: A Retrospective Cohort Study
title_sort subcutaneous emphysema, pneumomediastinum, and pneumothorax in critically ill patients with coronavirus disease 2019: a retrospective cohort study
topic Observational Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515614/
https://www.ncbi.nlm.nih.gov/pubmed/33063043
http://dx.doi.org/10.1097/CCE.0000000000000210
work_keys_str_mv AT joneseben subcutaneousemphysemapneumomediastinumandpneumothoraxincriticallyillpatientswithcoronavirusdisease2019aretrospectivecohortstudy
AT gouldallon subcutaneousemphysemapneumomediastinumandpneumothoraxincriticallyillpatientswithcoronavirusdisease2019aretrospectivecohortstudy
AT pillaytimeshd subcutaneousemphysemapneumomediastinumandpneumothoraxincriticallyillpatientswithcoronavirusdisease2019aretrospectivecohortstudy
AT khorasaneereza subcutaneousemphysemapneumomediastinumandpneumothoraxincriticallyillpatientswithcoronavirusdisease2019aretrospectivecohortstudy
AT sykesrichard subcutaneousemphysemapneumomediastinumandpneumothoraxincriticallyillpatientswithcoronavirusdisease2019aretrospectivecohortstudy
AT bazoalvarezjuancarlos subcutaneousemphysemapneumomediastinumandpneumothoraxincriticallyillpatientswithcoronavirusdisease2019aretrospectivecohortstudy
AT coxcharlie subcutaneousemphysemapneumomediastinumandpneumothoraxincriticallyillpatientswithcoronavirusdisease2019aretrospectivecohortstudy
AT shurovibadrun subcutaneousemphysemapneumomediastinumandpneumothoraxincriticallyillpatientswithcoronavirusdisease2019aretrospectivecohortstudy
AT istedalexander subcutaneousemphysemapneumomediastinumandpneumothoraxincriticallyillpatientswithcoronavirusdisease2019aretrospectivecohortstudy
AT simpsonthomas subcutaneousemphysemapneumomediastinumandpneumothoraxincriticallyillpatientswithcoronavirusdisease2019aretrospectivecohortstudy
AT jenningsmick subcutaneousemphysemapneumomediastinumandpneumothoraxincriticallyillpatientswithcoronavirusdisease2019aretrospectivecohortstudy
AT breezerichard subcutaneousemphysemapneumomediastinumandpneumothoraxincriticallyillpatientswithcoronavirusdisease2019aretrospectivecohortstudy
AT khaliqwaqas subcutaneousemphysemapneumomediastinumandpneumothoraxincriticallyillpatientswithcoronavirusdisease2019aretrospectivecohortstudy